AAAAAA
Results:
1-12
|
Results: 12
Authors:
Riemann, B
Kopka, K
Stogbauer, F
Halfter, H
Ketteler, S
Phan, TQV
Franzius, C
Weckesser, M
Ringelstein, EB
Schober, O
Citation: B. Riemann et al., Kinetic parameters of 3-[I-123]iodo-L-alpha-methyl tyrosine ([I-123]IMT) transport in human GOS3 glioma cells, NUCL MED BI, 28(3), 2001, pp. 293-297
Authors:
Young, P
Grote, K
Kuhlenbaumer, G
Debus, O
Kurlemann, H
Halfter, H
Funke, H
Ringelstein, EB
Stogbauer, E
Citation: P. Young et al., Mutation analysis in Charcot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity, J NEUROL, 248(5), 2001, pp. 410-415
Authors:
Friedrich, M
Hoss, N
Stogbauer, F
Senner, V
Paulus, W
Ringelstein, EB
Halfter, H
Citation: M. Friedrich et al., Complete inhibition of in vivo glioma growth by oncostatin M, J NEUROCHEM, 76(5), 2001, pp. 1589-1592
Authors:
Kopka, K
Riemann, B
Friedrich, M
Winters, S
Halfter, H
Weckesser, M
Stogbauer, F
Ringelstein, EB
Schober, O
Citation: K. Kopka et al., Characterization of 3-[I-123]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats, J NEUROCHEM, 76(1), 2001, pp. 97-104
Authors:
Riemann, B
Stogbauer, F
Kopka, K
Halfter, H
Lasic, M
Schirmacher, A
Kuwert, T
Weckesser, M
Ringelstein, EB
Schober, O
Citation: B. Riemann et al., Kinetics of 3-[I-123]iodo-L-alpha-methyltyrosine transport in rat C6 glioma cells (vol 27, pg 1274, 2000), EUR J NUCL, 27(12), 2000, pp. 1870-1870
Authors:
Riemann, B
Stogbauer, F
Kopka, K
Halfter, H
Lasic, M
Schirmacher, A
Kuwert, T
Weckesser, M
Ringelstein, EB
Schober, O
Citation: B. Riemann et al., Kinetics of 3-[I-123]iodo-L-alpha-methyltyrosine transport in rat C6 glioma cells (vol 27, pg 1870, 2000), EUR J NUCL, 27(12), 2000, pp. 1870-1870
Authors:
Thier, M
Roeb, E
Breuer, B
Bayer, TA
Halfter, H
Weis, J
Citation: M. Thier et al., Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate, CANCER LETT, 149(1-2), 2000, pp. 163-170
Authors:
Halfter, H
Postert, C
Friedrich, M
Ringelstein, EB
Stogbauer, F
Citation: H. Halfter et al., Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells, MOL BRAIN R, 80(2), 2000, pp. 198-206
Authors:
Halfter, H
Stogbauer, F
Friedrich, M
Serve, S
Serve, H
Ringelstein, EB
Citation: H. Halfter et al., Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on Stat3 or on mitogen-activated protein kinase activation, J NEUROCHEM, 75(3), 2000, pp. 973-981
Authors:
Mizuki, M
Fenski, R
Halfter, H
Matsumura, I
Schmidt, R
Muller, C
Gruning, R
Kratz-Abers, K
Serve, S
Steur, C
Buchner, T
Kienast, J
Kanakura, Y
Berdel, WE
Serve, H
Citation: M. Mizuki et al., Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways, BLOOD, 96(12), 2000, pp. 3907-3914
Authors:
Riemann, B
Stogbauer, F
Kopka, K
Halfter, H
Lasic, M
Schirmacher, A
Kuwert, T
Weckesser, M
Ringelstein, EB
Schober, O
Citation: B. Riemann et al., Kinetics of 3-[I-123]iodo-L-alpha-methyltyrosine transport in rat C6 glioma cells, EUR J NUCL, 26(10), 1999, pp. 1274-1278
Authors:
Weis, J
Schonrock, LM
Zuchner, SL
Lie, DC
Sure, U
Schul, C
Stogbauer, F
Ringelstein, EB
Halfter, H
Citation: J. Weis et al., CNTF and its receptor subunits in human gliomas, J NEURO-ONC, 44(3), 1999, pp. 243-253
Risultati:
1-12
|